Temporal trends in the prescription of vitamin K antagonists in patients with atrial fibrillation
Article first published online: 13 DEC 2005
Journal of Internal Medicine
Volume 259, Issue 2, pages 173–178, February 2006
How to Cite
FRIBERG, J., GISLASON, G. H., GADSBOELL, N., RASMUSSEN, J. N., RASMUSSEN, S., ABILDSTROM, S. Z., KØBER, L., MADSEN, M. and TORP-PEDERSEN, C. (2006), Temporal trends in the prescription of vitamin K antagonists in patients with atrial fibrillation. Journal of Internal Medicine, 259: 173–178. doi: 10.1111/j.1365-2796.2005.01595.x
- Issue published online: 13 DEC 2005
- Article first published online: 13 DEC 2005
- 8ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. Eur Heart J 2001; 22: 1852–923., , et al.
- 20Stroke Prevention in Atrial Fibrillation Investigators. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study. Lancet 1994; 343: 687–91.